Ali Raja, MD
Neurological Surgery · Flagstaff, AZNPI 1013131275
Payments from drug & device makers
Across 45 payments — averaging $322.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novocure Inc.$6K
- Nevro Corp.$5K
- Medtronic$1K
- Stryker$838
- Boston Scientific$821
- Johnson & Johnson$179
- plus $536 from 9 others
What the payments were for
- Speaking & faculty fees$4,00028%
- Travel & lodging$2,70219%
- Food & beverage$1,76612%
- Education$6,05342%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novocure Inc. | 11 | $5,563 |
| Nevro Corp. | 8 | $5,449 |
| Medtronic | 2 | $1,133 |
| Stryker | 3 | $838 |
| Boston Scientific | 7 | $821 |
| Johnson & Johnson(2 entities) | 5 | $179 |
| Carlsmed, Inc. | 1 | $170 |
| Providence Medical Technology, Inc. | 1 | $127 |
| Cerapedics Inc. | 1 | $67 |
| Xtant Medical Inc | 1 | $38 |
| Biosense Webster, Inc. | 1 | $35 |
| Spinal Elements, Inc. | 1 | $27 |
| Pulmonx Corporation | 1 | $26 |
| Abbott | 1 | $23 |
| Si-bone, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Oncology$5,331
- Senza$5,078
- IVS - VERTEBRAL AUGMENTATION PRODUCTS$639
- WaveWriter Alpha Prime 16$618
- aprevo$170
- Omnia$134
- STRYKER NAV3I$123
How this compares
$14,520 in reported general payments places this provider in the 60th percentile of 173 neurological surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 14 | $204,220 |
| Naloxone Hcl | 26 | $1,720 |
| Cephalexin | 45 | $330 |
| Clindamycin Hcl | 20 | $259 |
| Oxycodone Hcl | 45 | $179 |
| Diazepam | 14 | $6 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Flagstaff
- Stephen RitlandFlagstaff$179K
- Nader SanaiPhoenix$142.7M
- Robert SpetzlerPhoenix$13.2M
- Juan UribePhoenix$6.9M
- Stephen PapadopoulosPhoenix$6M
- Volker SonntagPhoenix$2M
- Jay TurnerPhoenix$1.4M
- Richard ChuaTucson$1.3M
- Steve ChangChandler$1.1M
- Michael LawtonPhoenix$876K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.